Quick Answer
Adaptimmune Therapeutics PLC reported Total Assets of $245.96 million for fiscal year 2024.
Adaptimmune Therapeutics PLC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $245.96M | -13.0% |
| 2023 | $282.62M | -14.1% |
| 2022 | $328.92M | -30.0% |
| 2021 | $469.55M | +4.1% |
| 2020 | $451.14M | +148.5% |
| 2019 | $181.54M | -34.4% |
| 2018 | $276.74M | -1.6% |
| 2017 | $281.15M | +19.9% |
| 2016 | $234.51M | -18.0% |
| 2015 | $285.82M | -4.9% |
| 2015 | $300.65M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | $130.63M | -59.4% | -17.4% |
| March 31, 2025 | $158.07M | -38.7% | -35.7% |
| December 31, 2024 | $245.96M | -13.0% | -22.5% |
| September 30, 2024 | $317.44M | +7.0% | -1.3% |
| June 30, 2024 | $321.70M | -6.2% | +24.7% |
| March 31, 2024 | $258.01M | -10.4% | -8.7% |
| December 31, 2023 | $282.62M | -14.1% | -4.7% |
| September 30, 2023 | $296.64M | -10.7% | -13.5% |
- Adaptimmune Therapeutics PLC showed a decrease of -13.0% in Total Assets compared to the prior fiscal year.
- Over the 2015–2024 period, Adaptimmune Therapeutics PLC’s total assets has declined by 18.2% (from $300.65 million to $245.96 million).
- The most recent figure is from Adaptimmune Therapeutics PLC’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: